Dr.Navas-Kmct Medicare Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 23-12-2024
- Paid Up Capital ₹ 0.10 M
as on 23-12-2024
- Company Age 7 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Revenue %
(FY 2022)
- Profit 359.85%
(FY 2022)
- Ebitda 18.18%
(FY 2022)
- Net Worth 218.36%
(FY 2022)
- Total Assets 226.58%
(FY 2022)
About Dr.Navas-Kmct Medicare
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Navas Moidu and Ayisha Nazreen serve as directors at the Company.
- CIN/LLPIN
U85300KL2017PTC049246
- Company No.
049246
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
25 May 2017
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ernakulam
Industry
Company Details
- Location
Kozhikode, Kerala, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Dr.Navas-Kmct Medicare?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Navas Moidu  | Director | 25-May-2017 | Current |
| Ayisha Nazreen | Director | 25-May-2017 | Current |
Financial Performance of Dr.Navas-Kmct Medicare.
Dr.Navas-Kmct Medicare Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 359.85% increase in profit. The company's net worth Soared by an impressive increase of 218.36%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Dr.Navas-Kmct Medicare?
Unlock access to Dr.Navas-Kmct Medicare's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Kmct Innovation And Incubation CouncilActive 2 years 9 monthsNavas Moidu and Ayisha Nazreen are mutual person
- Dr.Navas-Kmct Wellness Private LimitedActive 2 years 9 months
Navas Moidu and Ayisha Nazreen are mutual person
Dr.Navas-Kmct Developers LlpActive 7 years 11 monthsNavas Moidu and Ayisha Nazreen are mutual person
- Chemnad Healthcare FoundationActive 7 years 9 months
Navas Moidu and Ayisha Nazreen are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Dr.Navas-Kmct Medicare?
Unlock and access historical data on people associated with Dr.Navas-Kmct Medicare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dr.Navas-Kmct Medicare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dr.Navas-Kmct Medicare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
